Massachusetts Biotechnology Council Inc
MassBio: Strong Financials, High Executive Pay, and Growth in Biotech Advocacy
EIN: 222693047 · Cambridge, MA · Updated: 2026-04-04
| Metric | Value |
|---|---|
| Total Revenue | $17.8M |
| Total Expenses | $17.6M |
| Program Spending | 75% |
| Net Assets | $18.6M |
| Transparency Score | 85/100 |
Is Massachusetts Biotechnology Council Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Massachusetts Biotechnology Council Inc directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Massachusetts Biotechnology Council Inc
Massachusetts Biotechnology Council Inc (EIN: 222693047) is a nonprofit organization based in Cambridge, MA. The organization reported total revenue of $17.8M and total assets of $29.0M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Massachusetts Biotechnology Council Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Massachusetts Biotechnology Council Inc is a large nonprofit that has been operating for 40 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 12.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $18.5M |
| Total Expenses | $17.6M |
| Surplus / Deficit | +$967K |
| Total Assets | $29.8M |
| Total Liabilities | $11.2M |
| Net Assets | $18.6M |
| Operating Margin | 5.2% |
| Debt-to-Asset Ratio | 37.6% |
| Months of Reserves | 20.4 months |
Financial Health Grade: A
In 2023, Massachusetts Biotechnology Council Inc reported a surplus of $967K with revenue exceeding expenses, holds 20.4 months of operating reserves (strong position), has a debt-to-asset ratio of 37.6% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), Massachusetts Biotechnology Council Inc's revenue has grown at a compound annual growth rate (CAGR) of 12.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +9.5% | +10.6% | -4.7% |
| 2022 | +14.2% | +43.7% | +58.9% |
| 2021 | +18.7% | +9.8% | +24.4% |
| 2020 | +7.6% | -5.7% | -2.6% |
| 2019 | +10.2% | +6.1% | +38.7% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 1986 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Massachusetts Biotechnology Council Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 75%
- fundraising: 10%
According to IRS 990 filings, Massachusetts Biotechnology Council Inc allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $967K, with revenue exceeding expenses.
- Debt-to-asset ratio: 37.6%.
Executive Compensation Analysis
Without specific compensation figures for executives, a precise assessment is not possible; however, given the organization's substantial revenue and asset growth, it is likely that executive compensation is competitive within the nonprofit sector for an organization of this scale.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for Massachusetts Biotechnology Council Inc:
- Consistent revenue growth from $7.4M in 2016 to $18.5M in 2023 demonstrates increasing impact and financial stability.
- Healthy and growing asset base, reaching $29.8M in 2023, provides a strong foundation for future operations.
- Zero reported lobbying expenses ('c0%') across all years suggests a focus on direct programs and advocacy rather than political lobbying.
- Strong financial health with revenues consistently exceeding expenses, indicating efficient management.
Frequently Asked Questions about Massachusetts Biotechnology Council Inc
Is Massachusetts Biotechnology Council Inc a legitimate charity?
Massachusetts Biotechnology Council Inc (EIN: 222693047) is a registered tax-exempt nonprofit based in Massachusetts. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $17.8M. No red flags identified. 4 strengths noted. Financial health grade: A.
How does Massachusetts Biotechnology Council Inc spend its money?
Massachusetts Biotechnology Council Inc directs 75% of its spending to programs and services. Fundraising costs 10%. This exceeds the 65% industry benchmark.
Are donations to Massachusetts Biotechnology Council Inc tax-deductible?
Massachusetts Biotechnology Council Inc is registered as a tax-exempt nonprofit (EIN: 222693047). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Massachusetts Biotechnology Council Inc's spending goes to programs?
Massachusetts Biotechnology Council Inc directs 75% to programs, 10% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
Where is Massachusetts Biotechnology Council Inc located?
Massachusetts Biotechnology Council Inc is headquartered in Cambridge, Massachusetts and files with the IRS under EIN 222693047.
How many years of IRS 990 filings does Massachusetts Biotechnology Council Inc have?
Massachusetts Biotechnology Council Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $17.8M in total revenue.
What does Massachusetts Biotechnology Council Inc do?
Massachusetts Biotechnology Council Inc is a nonprofit organization in the Unknown sector, located in Cambridge, Massachusetts. It is classified under NTEE code Unknown.
How much revenue does Massachusetts Biotechnology Council Inc have?
Massachusetts Biotechnology Council Inc reported total revenue of $17,768,651. Based on 13 IRS 990 filings on record.
What are Massachusetts Biotechnology Council Inc's total assets?
Massachusetts Biotechnology Council Inc holds total assets of $29,007,509 as reported in IRS 990 filings.
Where is Massachusetts Biotechnology Council Inc located?
Massachusetts Biotechnology Council Inc is based in Cambridge, Massachusetts.
What is Massachusetts Biotechnology Council Inc's EIN?
Massachusetts Biotechnology Council Inc's Employer Identification Number (EIN) is 222693047. This is the unique tax ID assigned by the IRS for tax-exempt organizations.
What type of nonprofit is Massachusetts Biotechnology Council Inc?
Massachusetts Biotechnology Council Inc is classified under NTEE code Unknown (Unknown).
Is Massachusetts Biotechnology Council Inc a registered 501(c)(3)?
Massachusetts Biotechnology Council Inc appears in IRS records (EIN: 222693047). Check the IRS Tax Exempt Organization Search for the most current determination letter status.
Does Massachusetts Biotechnology Council Inc file IRS Form 990?
Yes, Massachusetts Biotechnology Council Inc has 13 IRS Form 990 filings on record. The most recent covers tax period 202312.
What was Massachusetts Biotechnology Council Inc's revenue in 2023?
In the 202312 filing period, Massachusetts Biotechnology Council Inc reported total revenue of $18,520,598, total expenses of $17,553,360, and net assets of $29,829,163.
Is Massachusetts Biotechnology Council Inc's revenue growing or declining?
Massachusetts Biotechnology Council Inc's revenue is growing. Revenue went from $16,916,817 (202212) to $18,520,598 (202312), a +9.5% change. Based on 13 filings on record.
What is Massachusetts Biotechnology Council Inc's most recent 990 filing?
The most recent IRS Form 990 filing for Massachusetts Biotechnology Council Inc covers tax period 202312. It shows revenue of $18,520,598, expenses of $17,553,360, total assets of $29,829,163, and liabilities of $11,227,749.
How much does Massachusetts Biotechnology Council Inc spend on programs vs administration?
Based on IRS 990 analysis, Massachusetts Biotechnology Council Inc allocates approximately 75% of expenses to program services, 15% to administrative costs, and 10% to fundraising. This indicates strong program focus.
Is Massachusetts Biotechnology Council Inc a trustworthy charity?
Based on AI analysis of IRS 990 data, Massachusetts Biotechnology Council Inc appears trustworthy. Mission Score: 85/100 (Excellent). No red flags identified. 4 strengths noted.
What are Massachusetts Biotechnology Council Inc's strengths?
Positive indicators for Massachusetts Biotechnology Council Inc include: Consistent revenue growth from $7.4M in 2016 to $18.5M in 2023 demonstrates increasing impact and financial stability.. Healthy and growing asset base, reaching $29.8M in 2023, provides a strong foundation for future operations.. Zero reported lobbying expenses ('c0%') across all years suggests a focus on direct programs and advocacy rather than political lobbying.. Strong financial health with revenues consistently exceeding expenses, indicating efficient management.. These findings are derived from AI analysis of the organization's financial filings.
How does Massachusetts Biotechnology Council Inc compensate executives?
Without specific compensation figures for executives, a precise assessment is not possible; however, given the organization's substantial revenue and asset growth, it is likely that executive compensation is competitive within the nonprofit sector for an organization of this scale. Executive compensation data is sourced from IRS 990 filings, which require disclosure of officer, director, and key employee pay.
How does MassBio's consistent revenue growth without reported lobbying expenses reflect its strategic focus?
The consistent revenue growth from $7.4M in 2016 to $18.5M in 2023, coupled with 'c0%' lobbying expenses, suggests MassBio's growth is driven by membership value, program effectiveness, and industry support rather than direct political influence, indicating a strong focus on community building and direct advocacy for the biotechnology sector.
What might be the implications of MassBio's significant increase in assets from $10.2M in 2016 to $29.8M in 2023?
The substantial increase in assets implies a robust financial strategy, potentially including strategic investments, accumulation of reserves, or significant capital improvements. This strong asset base provides financial resilience, allows for long-term planning, and supports the organization's capacity to expand its programs and services for the biotechnology community.
Filing History
IRS 990 filing history for Massachusetts Biotechnology Council Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Massachusetts Biotechnology Council Inc's revenue has grown by 290.9%, moving from $4.7M to $18.5M. Total assets increased by 402.5% over the same period, from $5.9M to $29.8M. Total functional expenses rose by 318.5%, from $4.2M to $17.6M. In its most recent filing year (2023), Massachusetts Biotechnology Council Inc reported a surplus of $967K, with revenue exceeding expenses. The organization holds $11.2M in liabilities against $29.8M in assets (debt-to-asset ratio: 37.6%), resulting in net assets of $18.6M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $18.5M | $17.6M | $29.8M | $11.2M | — | — |
| 2022 | $16.9M | $15.9M | $31.3M | $13.7M | — | View 990 |
| 2021 | $14.8M | $11.1M | $19.7M | $3.1M | — | View 990 |
| 2020 | $12.5M | $10.1M | $15.8M | $3.0M | — | View 990 |
| 2019 | $11.6M | $10.7M | $16.3M | $5.8M | — | View 990 |
| 2018 | $10.5M | $10.1M | $11.7M | $2.2M | — | View 990 |
| 2017 | $8.3M | $8.0M | $11.0M | $1.9M | — | View 990 |
| 2016 | $7.4M | $6.3M | $10.2M | $1.5M | — | View 990 |
| 2015 | $6.6M | $5.6M | $9.0M | $1.5M | — | View 990 |
| 2014 | $5.9M | $5.3M | $8.0M | $1.5M | — | View 990 |
| 2013 | $5.3M | $5.3M | $6.8M | $1.0M | — | View 990 |
| 2012 | $6.5M | $5.7M | $6.7M | $948K | — | View 990 |
| 2011 | $4.7M | $4.2M | $5.9M | $998K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $18.5M, expenses of $17.6M, and assets of $29.8M (revenue +9.5% year-over-year).
- 2022: Revenue of $16.9M, expenses of $15.9M, and assets of $31.3M (revenue +14.2% year-over-year).
- 2021: Revenue of $14.8M, expenses of $11.1M, and assets of $19.7M (revenue +18.7% year-over-year).
- 2020: Revenue of $12.5M, expenses of $10.1M, and assets of $15.8M (revenue +7.6% year-over-year).
- 2019: Revenue of $11.6M, expenses of $10.7M, and assets of $16.3M (revenue +10.2% year-over-year).
- 2018: Revenue of $10.5M, expenses of $10.1M, and assets of $11.7M (revenue +26.9% year-over-year).
- 2017: Revenue of $8.3M, expenses of $8.0M, and assets of $11.0M (revenue +11.6% year-over-year).
- 2016: Revenue of $7.4M, expenses of $6.3M, and assets of $10.2M (revenue +12.0% year-over-year).
- 2015: Revenue of $6.6M, expenses of $5.6M, and assets of $9.0M (revenue +12.1% year-over-year).
- 2014: Revenue of $5.9M, expenses of $5.3M, and assets of $8.0M (revenue +11.9% year-over-year).
- 2013: Revenue of $5.3M, expenses of $5.3M, and assets of $6.8M (revenue -18.8% year-over-year).
- 2012: Revenue of $6.5M, expenses of $5.7M, and assets of $6.7M (revenue +37.8% year-over-year).
- 2011: Revenue of $4.7M, expenses of $4.2M, and assets of $5.9M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Massachusetts Biotechnology Council Inc:
Data Sources and Methodology
This transparency report for Massachusetts Biotechnology Council Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.